Composition comprising a eukaryotic microalgae or an extract thereof for use in the treatment of a viral disease

Abstract

A composition is provided, including eukaryotic microalgae or an extract thereof for treatment of a viral disease such as coronavirus, and for use as an inhibitor of the binding of Spike protein receptor binding domain (RBD) to Angiotensin-Converting Enzyme 2 (ACE2). A compound derivable from the eukaryotic microalgae is also provided for treatment of a viral disease. A composition is also provided, including prokaryotic microalgae or an extract thereof for treatment of a viral disease.

Dependencies are inferred from the claim text.